Fiorucci, S., Antonelli, E., Morelli, O., Mencarelli, A., Casini, A., Mello, T., . . . Morelli, A. (2001). NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. The National Academy of Sciences.
Styl ChicagoFiorucci, Stefano, et al. NCX-1000, a NO-releasing Derivative of Ursodeoxycholic Acid, Selectively Delivers NO to the Liver and Protects against Development of Portal Hypertension. The National Academy of Sciences, 2001.
Citace podle MLAFiorucci, Stefano, et al. NCX-1000, a NO-releasing Derivative of Ursodeoxycholic Acid, Selectively Delivers NO to the Liver and Protects against Development of Portal Hypertension. The National Academy of Sciences, 2001.